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In the developing cerebral cortex, sequential transcriptional programs take neuroepithelial cells from proliferating progenitors to dif-
ferentiated neurons with uniquemolecular identities. The regulatory changes that occur in the chromatin of the progenitors are not well
understood. During deep layer neurogenesis, we show that transcription factor LHX2 binds to distal regulatory elements of Fezf2 and
Sox11, critical determinants of neuron subtype identity in the mouse neocortex. We demonstrate that LHX2 binds to the nucleosome
remodeling and histone deacetylase histone remodeling complex subunits LSD1, HDAC2, and RBBP4, which are proximal regulators of
the epigenetic state of chromatin. When LHX2 is absent, active histone marks at the Fezf2 and Sox11 loci are increased. Loss of LHX2
produces an increase, and overexpression of LHX2 causes a decrease, in layer 5 Fezf2 andCTIP2-expressing neurons. Our results provide
mechanistic insight into how LHX2 acts as a necessary and sufficient regulator of genes that control cortical neuronal subtype identity.
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Introduction
The complex functions of the cerebral cortex arise from circuitry
in which distinct neuronal subtypes serve specific functions. The
diversity of cortical neurons arises from initially common pro-
genitors in the ventricular zone. Work from several groups has
identified a complex network of transcriptional controls for the
specification, differentiation, diversity, and plasticity of neuronal
subtype identity (Arlotta et al., 2005; Woodworth et al., 2012;
Greig et al., 2013). FEZF2 is necessary for the specification of
subcerebral projection neurons (SCPN), the dominant popula-
tion of layer 5 output neurons. It is sufficient for SCPN genera-
tion from cortical progenitors during development in vivo (Chen
et al., 2005; Molyneaux et al., 2005). Further, SOX4, SOX5,
SOX11, and TBR1 are upstream regulators of Fezf2 expression in
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Significance Statement
The functional complexity of the cerebral cortex arises from an array of distinct neuronal subtypes with unique connectivity
patterns that are produced fromcommonprogenitors. This study reveals that transcription factor LHX2 regulates the numbers of
specific cortical output neuron subtypes by controlling the genes that are required to produce them. Loss or increase in LHX2
during neurogenesis is sufficient to increase or decrease, respectively, a particular subcerebrally projecting population. Mecha-
nistically, LHX2 interacts with chromatin modifying protein complexes to edit the chromatin landscape of its targets Fezf2 and
Sox11, which regulates their expression and consequently the identities of the neurons produced. Thus, LHX2 is a key component
of the control network for producing neurons that will participate in cortical circuitry.
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the cerebral cortex, with the SOX factors binding at downstream
enhancer element (E4) and TBR1 binding at 3 noncoding region
of Fezf2 (Kwan et al., 2008; Lai et al., 2008; Bedogni et al., 2010;
Han et al., 2011; McKenna et al., 2011; Shim et al., 2012). It is
increasingly understood that dynamic control over timing and
levels of expression of key regulators is required to determine the
generation of distinct neuronal subtypes in the cortical plate:
SCPN in layer 5 versus corticothalamic projection neurons
(CThPN) in layer 6 (Lai et al., 2008; Tomassy et al., 2010; Ceder-
quist et al., 2013; Greig et al., 2013). Control of gene expression
involves regulation of the chromatin at the relevant loci. How-
ever, our understanding of the dynamic chromatin regulation of
gene loci involved in neuronal subtype specification remains in-
adequate. Such understanding is required to address the funda-
mental open question of how overlapping transcription factors
expressed in the ventricular zone are translated into instructions
to produce precise sets of neuronal subtypes in a temporal se-
quence. Here, we report a previously unknown role for the LIM-
homeodomain transcription factor LHX2, as a key regulator of
Fezf2 and Sox11 that is well positioned to function early in the
cascade of mechanisms that specify SCPN identity.
LHX2 has a fundamental role in early cortical specification, in
which it acts as a cortical selector gene (Mangale et al., 2008).
However, Lhx2 continues to be expressed in the ventricular zone
throughout the period of cortical neurogenesis and displays
intriguing spatiotemporal dynamics (Bulchand et al., 2003).
Whereas neurons of deep layers 5 and 6 rapidly repress Lhx2
expression, superficial layer neurons continue to express LHX2
from their birth dates through maturity (Bulchand et al., 2003).
We hypothesized that the dynamic regulation of Lhx2 might be
important for the production of particular neuronal subtypes
that predominate in deep versus superficial layers.
In this paper, we report the first evidence that LHX2 regulates
cortical neuronal subtype identity. Loss of LHX2 function causes
a striking increase in the layer 5 neurons expressing high levels of
Fezf2 and CTIP2, indicating SCPN fate (Arlotta et al., 2005;
Molyneaux et al., 2005). It also causes a reduction in layer 6
neurons expressing TBR1 (predominantly CThPN fate) (Hevner
et al., 2001; McKenna et al., 2011). We performed chromatin
immunoprecipitation followed by sequencing (ChIP-Seq), and
identified LHX2 occupancy on distal regulatory elements associ-
ated with Fezf2 and its regulator, Sox11. To elucidate the mecha-
nisms by which LHX2 might regulate Fezf2 and Sox11, we
performed protein IP followed by mass spectrometry and identi-
fied members of the nucleosome remodeling and histone
deacetylase (NuRD) complex of chromatin regulators to be bind-
ing partners of LHX2. The transcription start sites (TSSs) and the
LHX2 binding sites of both Fezf2 and Sox11 are epigenetically
modified in an LHX2-dependent manner and display histone
marks corresponding to the activity of NuRD complex. Finally,
we show that LHX2 overexpression causes a decrease in the high
Fezf2/CTIP2-expressing (SCPN) population. Together, these
results demonstrate that LHX2 is both necessary and sufficient to
regulate the numbers of deep layer 5 corticofugal projection neu-
rons that express the Fezf2/CTIP2 signature and that it functions
by modulating the epigenetic marks on key factors that control
cortical neuron subtype identity.
Materials andMethods
Mice. All animal protocols were approved by the Institutional Animal
Ethics Committee (Tata Institute of Fundamental Research, Mumbai,
India) according to regulations formulated by the Committee for the
Purpose of Control and Supervision of Experiments onAnimals, India. The
floxed LIMhomeobox2 (Lhx2) line (Lhx2lox/lox) andEmx1CreYL lines used
in this study have been described previously by Mangale et al. (2008). The
Emx1CreYL(Jin et al., 2000) was obtained as a gift from Prof. Yuqing Li at
University of Florida College of Medicine. The floxed Lhx2 line was a gift
from Prof. EdwinMonuki at the University of California, Irvine.
Timed pregnant female mice were obtained from the Tata Institute
animal breeding facility, and embryos of both sexes were used for the
experiments. Noon of the day the vaginal plug was observed was consid-
ered embryonic day (E) 0.5. Early-age embryos were staged by somite
number and genotyped using PCR. Animals were genotyped and as-
signed to groups accordingly. Controls used for each experiment were
age-matched littermates.
ChIP sequencing. For each ChIP sequencing experiment, 50 g chro-
matin and 4 g antibody were used per IP. To obtain chromatin, brains
from E12.5 embryos were harvested and the neocortical tissue was iso-
lated in cold 0.5% glucose in PBS with 1 Protease inhibitor mixture
(Sigma). The tissue was cross-linked immediately after harvesting with
1% formaldehyde (Thermo Scientific). Chromatin was sonicated using a
Covaris S220 sonicator for 18 cycles of 60 s ON and 30 s OFF (5% Duty
cycle, 2 Intensity and 200 cycles per burst) to get chromatin within the
size range of 100–500 bp. The following antibodies were used for ChIP:
goat-LHX2 (Santa Cruz Biotechnology SC19344), goat IgG (Bangalore
Genei). The protein-DNA complex was pulled down using Protein A-G
magnetic beads (Dynabeads, Invitrogen). The immunoprecipitated
DNAwas purified using phenol-chloroform-isoamyl alcohol (Ambion).
Sequencing libraries were prepared using SOLiD ChIP-Seq library prep-
aration kit, and sequencing was performed on the SOLiD 4 System
(Applied Biosystems). Five bases each were trimmed on the 5 and 3
ends, and reads were aligned to the reference genomemm9 using bowtie
1. Peaks were called using the MACS 1.4 program with default settings.
The UCSC browser was used for data visualization.
ChIP-qPCR. In each ChIP-qPCR experiment for validation of binding
of LHX2 and/or NURD complex protein members on LHX2 binding
regions andTSS, 10g chromatin and 2g antibodywas used per IP. For
each Histone mark ChIP-qPCR, 5 g chromatin and 1 g antibody was
used per IP. The following antibodies were used for ChIP: goat -LHX2
(Santa Cruz- SC19344), goat IgG (Bangalore Genei), rabbit anti-Kdm1a/
LSD1 (Abcam, #ab17721), rabbit anti-HDAC2 (Abcam, #ab7029), rabbit
anti-RBBP4 (Abcam, #ab38135), rabbit anti IgG (as control IgG for
NuRD complex protein ChIPs) (Sigma, #18140), anti-Histone H3 anti-
body (ab1791), rabbit anti-H3K4me3 (Diagenode, C15410030), rabbit
anti-H3K9ac (Diagenode, C15410004).
ChIP was performed as described above. For LHX2 and NURD com-
plex protein members, individual enrichment over the control genomic
region was assessed by performing ChIP-qPCR with primers specific for
these regions using the SYBR Green master mix (Roche). For histone
marks, ChIP signals for H3K4me3 and H3K9ac were normalized to total
H3. ChIP-qPCRs were done in duplicates, and at least three independent
experiments were performed for each ChIP-qPCR. For statistical analy-
sis, independent experiments were used to calculate average, SEM, and
significance value.
Information of the primers used for ChIP-qPCR is given (5 to 3) as
follows: LHX2 BR on Fezf2: forward, TAGGCATGGAACGCAATGTA;
reverse, TGGGACAGGAAGAAAAGACG; TSS Fezf2: forward, CCCTG-
GTGTCCGTCTAATCA; reverse, CGCCACATCCTAATGAGGTAA;
LHX2 BR on Sox11: forward, GCAGACACAGCCGTCCAT; reverse,
GGAACAATACACGGGTCTCC; TSS Sox11: forward, CACTACTC-
CCACCAGCCAAT; reverse, GCACTCGCGGATTTCTTTT; and con-
trol genomic region: forward, GGGTCACTGAGGCAAAAATC; reverse,
GCCTATCACCTGCAGGATTC.
IP and Western blotting: mass spectrometry. For mass spectrometric
analysis of the LHX2 interacting proteins, IP was performed using 10mg
of protein sample and 20 g of antibody. Brains from E15 embryos were
harvested in cold 0.5% glucose in PBS with 1 Protease inhibitor mix-
ture. For IP, samples were lysed in TNN buffer (50 mM Tris-Cl pH 7.5,
150 mMNaCl, 0.9%NP-40, 1 mM PMSF, 1 protease inhibitor mixture,
and 1 phosphatase inhibitor mixture) using a Dounce homogenizer.
The lysate was centrifuged at 13,000 rpm for 45 min at 4°C to remove
membranes and other debris. Supernatant was collected. Goat anti-
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LHX2 (Santa Cruz Biotechnology, SC 19344) was used for LHX2 pull-
down, and goat IgG (Bangalore Genei) was used as the negative control.
Themagnetic beads used for IP along with the precipitated proteins were
resuspended in Laemmli buffer (63 mM Tris-HCl, 2% SDS, 0.0025%
bromophenol blue, 10% glycerol) without -mercaptoethanol and
boiled at 65°C for 5 min. Proteins obtained by IP were resolved on 8%
SDS gel of 1 mm thickness. The gel was processed for silver staining, and
in-gel digestion was done according to the protocol described by
Shevchenko et al. (1996). Mass spectrometric analysis was done at the
Mass Spectrometry Facility, Tata Institute of Fundamental Research.
Three biological replicates of LHX2-IP material were subjected to mass
spectrometric analysis, and individual candidates were validated using
IP. -Mercaptoethanol was not included in the Laemmli buffer; there-
fore, the proteins tend to run at molecular weights higher than expected,
which is reflected in our data.
LHX2 IPs and reverse IPs. For the LHX2 IPs and reverse IPs (with
subunits of the NURD complex), the IP was performed using 500 g of
lysate and 1 g of antibody. For the LHX2 IPs, the same antibodies were
used that have been previouslymentioned formass spectrometry. For the
reverse IPs, the following antibodies were used: rabbit anti-KDM1A/
LSD1 (Abcam, #ab17721), rabbit anti-HDAC2 (Abcam, #ab7029), rabbit
anti-RBBP4 (Abcam, #ab38135), and rabbit anti-IgG (Sigma, #18140),
which was used as a control for all the reverse IPs. IPs were performed as
previously described for mass spectrometric analysis. The magnetic
beads used for IP along with the precipitated proteins were resuspended
in Laemmli buffer (63 mM Tris-HCl, 2% SDS, 0.0025% bromophenol
blue, 10% glycerol) without -mercaptoethanol and boiled at 65°C for 5
min for all the IPs other than the LHX2 IP probed with LSD1. LSD1 has
a high molecular weight, which makes the visualization of the band dif-
ficult in the IP lanes as IgG produces a dark band at higher molecular
weights. For this particular IP, the beads were resuspended in Laemmli
buffer with -mercaptoethanol and boiled at 95°C for 3 min to degrade
the IgG, which resulted in a band at 55 kDa, thus making the band
corresponding to LSD1 clearly visible. The resuspended samples were
run on SDS-containing gel and then transferred on a PVDF membrane
(Roche) in transfer buffer containing 20% methanol and 0.01% SDS at
90 V for 100 min. LHX2 affinity purified mouse monoclonal antibody,
custommade fromBioclone, was used at a dilution of 1:1000 for probing
the blots for the LHX2 IPs and reverse IPs. Themonoclonal antibodywas
validated before use. The aforementioned antibodies (anti-KDM1a, anti-
HDAC2, and anti-RBBP4) were used for probing the Western blots at a
dilution of 1:1000. Blots were developed using ECL substrate (GE
Healthcare). Three biological replicates for each IP were performed.
ISH. Digoxigenin-labeled RNA probes were used for ISH. Digoxigenin-
labeled NTPs were obtained from Roche and used to make riboprobes.
Brains were sectioned (30m) using a freezing microtome. The sections
were mounted on Superfrost Plus slides (Erie Scientific). After fixing in
4% (w/v) PFA, sections were washed with 1 PBS. The sections were
then treated with Proteinase K in TE buffer (1 g/ml). Postfixation was
done using 4% PFA, and the sections were washed with 1 PBS. The
sections were hybridized for 16 h at 70°C in buffer containing 50% (v/v)
formamide, 5 SSC and 1% (w/v) SDS. Stringent washes posthybridiza-
tion were performed with Solution X (50% formamide, 2 SSC, and 1%
SDS) followed by 2 SSC and then 0.2 SSC. Overnight incubation at
4°C with anti-digoxigenin antibody tagged with alkaline phosphatase
(1:5000, Roche, catalog #12486523). Antibody was detected using sub-
strate NBT/BCIP (Roche, 4-nitroblue tetrazolium chloride, catalog
#70210625; 5-bromo-4-chloro-3-idolyl phosphate, catalog #70251721).
Slides were counterstained with Fast Red (Sigma N3020), coverslipped
using DPX mountant, and imaged. ISH for each marker was performed
in at least four biological replicates.
Plasmids used for generating probes were obtained from JeffreyMack-
lis, Harvard University (Fezf2); Susan McConnell, Stanford University
(ER81); Anastassia Stoykova, University of Go¨ttingen (Id2); Edwin
Monuki, University of California, Irvine (Cux2); RobertHevner,Univer-
sity of Washington (Tbr1); and Cliff Ragsdale, University of Chicago
(Ror). Probes for Lhx2 and Sox11 were generated using PCR primers,
the information for which is given (5 to 3) as follows: Lhx2: forward,
GATGTAGCTGCCCCCACGCC; reverse, TGTGGAACAGCATCG-
CGGC; Sox11: forward, CGCTGGAAGATGCTGAAGGA; reverse,
CCAGCGACAGGGATAGGTTC.
Immunohistochemistry. Primary antibodies used were as follows: bio-
tinylated goat anti-GFP (1:400; Abcam, catalog #ab6658), rabbit anti-
TBR1 (1:200; Abcam, catalog #ab31940), rat anti-CTIP2 (1:200; Abcam,
catalog #ab18465), and mouse anti-SATB2 (1:200; Abcam, catalog
#ab51502). Secondary antibodies used were as follows: streptavidin
Alexa-488 (1:800; Invitrogen, catalog #S32354) forGFP.Goat anti-rabbit
antibody conjugated to Alexa-488 (1:400, Molecular Probes, catalog
#A11008) for TBR1. Goat anti-rat antibody conjugated to Alexa-568
(1:400,Molecular Probes, catalog #A11077) for CTIP2. Goat anti-mouse
antibody conjugated to Alexa-647 (1:400, Molecular Probes, catalog
#A21235) for SATB2. Tissue processing for immunohistochemistry was
performed as described by Subramanian et al. (2011). For each control
and experimental condition,100 cells were counted from each of five
biological replicates for Figure 1 and from each of three biological repli-
cates for Figure 5.
In utero electroporation.All procedures conducted followed the guide-
lines prescribed by the Institutional Animal Ethics Committee. Swiss
mice obtained from the Tata Institute of Fundamental Research animal
breeding facility were used for electroporation. E12.5 timed pregnant
mice were anesthetized using isoflurane (Forane, Abbott India). The
surgical procedure performed has previously been described by Subra-
manian et al. (2011). The 3–4 l plasmid DNA of concentration 2
g/l dissolved in nuclease freewater andmixedwith Fast Green dyewas
injected into the lateral ventricle of the embryos using a fine-glass micro-
capillary. For electroporation, a BTX CUY21 electroporator [32 V
(E12.5), 4 pulses, 50 ms pulse length, 1.0 s pulse interval was used.
Electric pulses were delivered using 3 mm paddle electrodes. The cortex
was targeted by placing the positive electrode on the side of the dorsal
wall of the lateral ventricle. The uterine horns were replaced, and the
incision was sewn with surgical sutures. Animals were kept on a 37°C
warmplate for half an hour for postsurgical recovery. An oral suspension
of Meloxicam (Melonex, United Pharmacies) was mixed with the water
in the feedingbottles of thedams(0.6l/ml) as ananalgesic andgiven to the
animals until 2 d after surgery.DNAconstructsLhx2-GFP and pCAGIRES2-
EGFPwere used as described by Subramanian et al. (2011).
Imaging. Bright-field images were taken using a Zeiss Axioplan 2 
microscope, Nikon Digital Sight DS-F12 camera, and Nikon NIS 4.0
imaging software. Images of immunohistochemistrywere obtainedusing
a Zeiss LSM5 Exciter-AxioImagerM1 imaging system and Zeiss LSM510
imaging system. Image stacks were generated by scanning at intervals of
4 m for lower magnification and at intervals of 0.8 m for higher
magnification using filters of the appropriate wavelengths. The stacks
were analyzed, merged, and projected using ImageJ software from the
National Institutes of Health. Figure panels were prepared using Adobe
Photoshop CS6.
Statistical analysis. Statistical analysis was performed using the un-
paired two-tailed Student’s t test. Error bars indicate SEM. All pri-
mary data from immunohistochemistry and ISH experiments were
analyzed by one investigator and then confirmed by a second, inde-
pendent investigator.
Results
Lhx2 is strongly expressed in the ventricular zone at embryonic
day (E) 12.5 and E15.5 (Fig. 1A, white asterisks) but is not detect-
able in postmitotic deep layer neurons accumulated in the corti-
cal plate from E15.5 onwards. By postnatal stages, deep layer
neurons do not detectably express Lhx2 (Fig. 1A, black asterisks).
We generated cortex-specific Lhx2 conditionalmutant brains us-
ing Emx1CreYL, which we have previously characterized as a re-
agent that achieves near-complete recombination in the dorsal
telencephalon by E11.5, a day later than the commonly used
Emx1CreKJ line (Shetty et al., 2013). The Emx1CreYL line is crucial
to the present study because it spares the neocortex (Shetty et al.,
2013); removing LHX2 from the dorsal telencephalon before
E11.5 using Emx1CreKJ causes a transformation of neocortex to
paleocortex (Chou et al., 2009). For the rest of this study,
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Emx1CreYL will be referred to as simply “Emx1Cre,” and the re-
sulting brains will be referred to as “cortex-specific conditional
mutant brains.”
In cortex-specific Lhx2 conditional mutant mice (Emx1CreYL)
(Shetty et al., 2013), as well as in the pan-CNS Lhx2 conditional
mutantmice (NestinCre) (Chou andO’Leary, 2013), the cortex is
thinner than in control brains. Although all layers are specified,
the later born superficial layers are considerably thinner in mu-
tant brains compared with controls. In these studies, the deep
layers 5 and 6 did not appear to be as drastically affected (Chou
and O’Leary, 2013; Shetty et al., 2013). In the present study, we
discovered a previously unreported phenotype in the deep layers
5 and 6 of cortex-specific Lhx2 conditional mutant brains.
On close examination of postnatal day (P) 7 brains, we found
that Tbr1-expressing layer 6 neurons are reduced in Lhx2 condi-
tional mutant brains compared with controls. In contrast, layer 5
is substantially expanded as revealed by the expression of ER81,
Id2, high-level Fezf2, andCTIP2, a downstream effector of FEZF2
(Fig. 1B,C,E) (Arlotta et al., 2005;Molyneaux et al., 2005; Chen et
al., 2008; Rouaux and Arlotta, 2013). Cell counts of CTIP2-
expressing and TBR1-expressing cells as a percentage of the total
DAPI-stained population (layers 5  6) confirms the increase
(CTIP2) and decrease (TBR1) in the respective populations (Fig.
1D,E). This suggested that LHX2may regulate neuronal subtype
fate specification.
To investigate this possibility, we harvested cortical primordia
from embryonic telencephalic hemispheres at E12.5, and per-
formed ChIP using anti-LHX2 antibody, followed by sequencing
(ChIP-Seq; Fig. 2A). We screened the loci associated with LHX2
binding regions for known regulators of cortical neuronal subtype
identity. Two candidates, Fezf2 and its known transcriptional regu-
lator Sox11 (Shim et al., 2012), displayed LHX2 occupancy on puta-
tive distal regulatory regions.
During deep layer neurogenesis, both these factors promote
layer 5 SCPN fate, and FEZF2 represses layer 6 TBR1 CThPN
fate (Molyneaux et al., 2005; Han et al., 2011; McKenna et al.,
2011). The LHX2 occupancy peaks for the Fezf2 and Sox11 loci
were at positions distant from the TSS, 7.8 and 266 kb, respec-
Figure 1. Cortex-specific loss of Lhx2 alters the expression of neuronal subtypemarkers in layers 5 and 6. A, Expression of Lhx2 in control brains is seen in the ventricular zone at E12.5 and E15.5
(white asterisks) but not in postmitotic deep layer neurons at E15.5 and P7 (black asterisks). B, C, Expression of neuronal subtype markers at P7 in control and LHX2cKO brains reveals a decrease in
the Tbr1-expressing population and an increase in the Fezf2, ER81, and Id2-expressing population. B, Boxed regions are shown in C. D, E, The numbers of cells expressing TBR1 or CTIP2, expressed
as a percentage of all DAPI-stained cells in layer 5 (L5) layer 6 (L6). Error bars indicate SEM. Scale bars, 500m. *p 0.05. **p 0.001.
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tively (Fig. 2C,E). These regions each contained an LHX2 binding
site sequence reported in the literature (Berger et al., 2008;Wilson et
al., 2008) (Fig. 2B). The LHX2 occupancy was further confirmed by
ChIP-qPCR using primers designed for the specific binding region
(Fig. 2D,F; for details, seeMaterials andMethods).
To test whether LHX2 expression in the ventricular zone reg-
ulates the transcription of Fezf2 and Sox11, we examined their
expression in E12.5 control and Lhx2 cortex-specific conditional
mutant brains (Fig. 2G). The Emx1CreYL driver causes wide-
spread recombination in the cortical primordium by E11.5
(Shetty et al., 2013).By E12.5, there was a striking upregulation of
Fezf2 in the ventricular zone in LHX2cKO brains compared with
controls. Sox11, normally only seen in postmitotic neurons, also
displayed amodest increase in the LHX2cKO ventricular zone. In
addition, both Fezf2- and Sox11-expressing cells were increased
in number in the cortical plate of LHX2cKO brains (Fig. 2G),
which is consistent with the increased numbers of Fezf2/CTIP2-
expressing cells seen postnatally (Fig. 1). This effect of increased
expression in the cortical plate was even more striking at E13.5,
by which stage the Fezf2/Sox11 upregulation in the ventricular
zone has attenuated (Fig. 2H). This suggests that LHX2-
mediated repression of Fezf2 and Sox11 is particularly important
in the E11.5–12.5 ventricular zone, corresponding to the peak of
layer 6/5 neurogenesis. The continued effects of loss of Lhx2 are
seen when the postmitotic neurons reach the cortical plate by
E13.5. Therefore, these data reveal that LHX2 binds distal regu-
Figure 2. LHX2 occupies enhancer elements of cortical neuron subtype regulators Fezf2 and Sox11. A, Diagram illustrating dissection of cortical primordia. B, The LHX2 binding site sequence
reported in the literaturewas also found in the LHX2 binding regions of Fezf2 and Sox11. C–F, ChIP-Seq data showingUCSC genome browser tracks of the LHX2 occupancy profile at the Fezf2 (C) and
the Sox11 (E) loci. Each LHX2-binding region was validated by ChIP followed by qPCR analysis (D,F ). G,H, Examination of Fezf2 and Sox11 at E12.5 (G), 1 d after cortex-specific loss of LHX2, reveals
an increased expression of Fezf2 and Sox11 in the ventricular zone (white asterisks) and an increased accumulation of Fezf2- and Sox11-expressing postmitotic cells (arrowhead). High-
magnification images are displayed alongside.H, By E13.5, the increase in the ventricular zone has attenuated (white asterisks), but the expression in the cortical plate has expanded (arrowhead).
Error bars indicate SEM. Scale bar, 100m. *p 0.05. **p 0.001.
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latory elements of Fezf2 and Sox11, and loss of LHX2 results in
upregulation of these genes in the cortical ventricular zone dur-
ing the time of peak production of SCPNs.
Transcription factors usually act in multimeric complexes to
achieve their functions (Vernimmen and Bickmore, 2015). To
identify binding partners of LHX2, we performed IP from corti-
cal tissue using anti-LHX2 antibody, and ran the resulting sam-
ples on an SDS-PAGEgel. Silver staining revealed bands thatwere
differentially enriched in comparison with a control IgG IP (Fig.
3A). These were excised and the proteins identified using mass
spectrometry.Mass spectrometry was performed for 2 additional
biological replicates of LHX2-IP material, for which all bands
were excised and sequenced. The resulting dataset was manually
curated for known chromatin modifiers. Three subunits associ-
atedwith theNuRD complex, LSD1, RBBP4, andHDAC2 (Wang
et al., 2009), were identified as potential binding partners of
LHX2. These were individually validated in three biological rep-
licates, by performing LHX2 IP followed by Western blotting
using antibodies against the specific NuRD complex proteins
(Fig. 3B). Reverse validations were also performed, in which
LSD1/RBBP4/HDAC2-specific antibodies were used for IP, and
the Western blot was probed with anti-LHX2 (Fig. 3C). Of the
known components of the NuRD complex, the subunits that
bind LHX2 are shown in color (Fig. 3D). Finally, we tested
whether these particular subunits bind the same regions as LHX2
on the Fezf2 and Sox11 loci. We also tested the TSSs of both these
genes. ChIP using anti-LSD1/anti-RBBP4/anti-HDAC2, fol-
lowed by qPCR, revealed that all three NuRD complex subunits
bind either the TSS and/or the LHX2 binding region (LHX2 BR)
of Fezf2 and/or Sox11. In summary, these data reveal that LHX2
binds to specific chromatin-regulatory factors that also bind the
distal LHX2 occupancy sites and/or the TSS of key neuronal sub-
type identity regulators Fezf2 and Sox11.
Epigenetic marks on the distal regulatory elements and the
TSSs are reflective of the transcription status of the gene, and
understanding the factors that bring this about gives a mechanis-
tic insight into the process. We examined whether epigenetic
marks on the TSS and the LHX2 binding regions of Fezf2 and
Sox11 were altered in Lhx2 mutant tissue. We harvested E12.5
tissue from control and LHX2cKO cortices and performed ChIP
using antibodies against two well-established active marks,
H3K4me3 andH3K9Ac (Karmodiya et al., 2012).We found both
these marks to be significantly enriched at the TSS and/or LHX2
BR of both Fezf2 and Sox11 in LHX2cKO tissue (Fig. 4A). There-
fore, the presence of LHX2 is essential to erase these marks at
these sites. Because LHX2 binds a region distant from the TSS, its
regulation of active marks at both sites may be explained by a
chromatin loopingmodel in which the putative enhancer and the
TSSs are brought near each other in the presence of LHX2. Such
a model would permit chromatin-modifying machinery, includ-
ing, but not limited to, the proteins we identified, to erase the
active marks. In the absence of LHX2, this function may be di-
Figure3. LHX2binds specific subunits of theNuRDcomplex.A, A silver-stainedgel showing control (IgG) andLHX2 IP fromcortical tissue. Boxes represent bands thatwere excisedand fromwhich
theproteinswere analyzedusingmass spectrometry.B, Putative LHX2bindingpartners identified in themass spectrometry (HDAC2, LSD1, andRBBP4)were validatedbyWesternblot (immunoblot)
analysis of LHX2 IPmaterial using antibodies against each candidate partner. C, Reverse validation of interactionswas performed by performing IP for each binding partner and probing theWestern
blot using anti-LHX2. D, Diagram illustrating the NuRD complex and members that bind LHX2. E, ChIP-qPCR-based occupancy analysis demonstrating the binding of LSD1, HDAC2, and RBBP4 to
either the TSS and/or the LHX2 binding region (LHX2 BR) on Fezf2 and/or Sox11. y-axis indicates fold enrichment over IgG at the respective loci. CHD4, Chromodomain helicase DNA binding protein
4; HDAC2, histone deacetylase 2; LSD1, lysine-specific histone demethylase1;MDB,methyl CpG binding domain protein;MTA1/2,metastasis-associated protein1/2; RBBP4, retinoblastoma binding
protein 4. A, The image of the silver-stained gel has been cropped to remove the lanes corresponding “unbound” fractions of control IgG and LHX2 IP that were on the left of the marker lane. B, C,
The Western blots are cropped from full-length Western blots. The original uncropped images are available upon request. Error bars indicate SEM. *p 0.05. **p 0.001. ***p 0.0001.
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minished, and the active marks are en-
riched (Fig. 4B), thereby leading to an
aberrant expression of Fezf2 and Sox11.
Loss of LHX2 results in increased activa-
tion/expression of target genes, and corre-
latedwith this, an increase in the number of
layer 5 Fezf2/CTIP2 neurons. We tested
whether overexpressionofLhx2wouldhave
the opposite effect of reducing the numbers
of these neurons. We used an LHX2-GFP
construct for in utero electroporation at
E12.5 (Fig. 5A,B).Thequantificationsdem-
onstrate that LHX2 overexpression causes a
50%decrease inCTIP2-expressing cells and
a 59% increase in SATB2-positive cells in
layer 5, consistent with a role for LHX2 in
modulating relative numbers of neurons
with distinct molecular subtype signatures
(Fig. 5D).
In summary, our results show that loss
or overexpression of Lhx2 regulates key
genes that specify neuronal subtype iden-
tity. LHX2 appears to achieve this regula-
tion by recruiting chromatin-modifying
proteins, and loss of LHX2 causes changes
in the epigenetic marks associated with its
target genes. These findings position
LHX2 as a critical component of the net-
work of factors that control the produc-
tion of an appropriate proportion of
neuronal subtypes in the developing cere-
bral cortex.
Discussion
We present an extensive mechanistic analysis of how LHX2, a
transcription factor expressed in the cortical ventricular zone,
can exert regulatory control on mechanisms that confer subtype
identity to cortical neurons.Emx1Cre acts in the ventricular zone,
and postmitotic neurons arising from these progenitors would
also be expected to carry any alleles that undergo recombination
as a result of the Emx1Cre action. Therefore, an obvious question
is whether the effects of LHX2 removal are relevant in the ven-
tricular zone progenitors themselves, or in the newly postmitotic
neurons they produce. A recent study that usedNexCre to delete
LHX2 specifically in postmitotic neurons starting fromE11 offers
clarity on this issue (Zembrzycki et al., 2015). This study elegantly
demonstrated thatNexCre action is not seen in proliferating pro-
genitors in the ventricular zone but is seen in newly postmitotic
cells (Zembrzycki et al., 2015, their Figure S2) and thatmolecular
specification of the different cortical layers is not affected (Zem-
brzycki et al., 2015, their Fig. 3). Therefore, the function of LHX2
we uncovered in the present study appears to be a novel role for
LHX2 that operates in ventricular zone progenitors, the effects of
which are seen by way of molecular dysregulation of its target
genes in the ventricular zone itself, and also evident in altered
proportions of cortical neuronal subtypes in maturity.
Loss of LHX2 in the cortical ventricular zone has been re-
ported to cause premature neurogenesis, resulting in a thicker
cortical plate during the early stages of corticogenesis and as a
consequence, depletion of the progenitor pool resulting in thin-
ner superficial layers (Chou et al., 2013). However, by postnatal
stages the combined effect of these two opposing phenomena
result in a cortex with diminished thickness compared with that
ofwild-type brains (Chou et al., 2013; Shetty et al., 2013). A defect
involving premature neurogenesis would be expected to leave the
earliest born layer 6 relatively unaffected and have a progres-
sively greater effect on the later born layers due to progenitor
depletion. Our present study uncovers a paradoxical phenotype,
such that layer 6 is thinner than normal, and layer 5 is expanded
compared with control brains (Fig. 1). This is not explained by a
progressive depletion of the progenitor pool (Chou et al., 2013)
but, rather, suggests an entirely different defect: that of neuronal
subtype fate specification. Removal of LHX2 leads to upregula-
tion of Fezf2 in the ventricular zone, which is known to suppress
Tbr1 (Mckenna et al., 2011). The decrease in layer6 TBR1 neu-
ronsmay not be a consequence of direct regulation by LHX2, but
an indirect result of Fezf2 upregulation in the absence of LHX2.
Therefore, in addition to its previously described role in regulat-
ing progenitor proliferation, this multifunctional transcription
factor also regulates neuronal subtype identity. This is the first
report of such a function for LHX2.
To provide a comprehensive understanding of the mechanisms
at play, studies of gene regulation should include both an examina-
tion of the protein complexes inwhich the regulatorymolecule acts,
as well as its occupancy on target gene loci. We report a novel mo-
lecular role for LHX2, in which it partners with proteins HDAC2,
LSD1, and RBBP4, that are found together in the NuRD-HDAC
complex. However, these proteins display differential occupancy on
Fezf2 and Sox11 in that RBBP4 does not appear to bind the Fezf2
locus on either the TSS or the LHX2 BR, whereas LSD1 binds both
these regions on both Fezf2 and Sox11, and HDAC2 does so only at
theLHX2BRonboth loci. This raises thepossibility thatmaynot act
togetherwithin theholo-NuRDcomplexbutmayact independently
or in other combinations in a site-specific context.
Figure4. Loss of LHX2 causes an increase in active epigenetic histonemarks on Fezf2 and Sox11.A, ChIP-qPCR for active histone
marks H3K4me3 and H3K9ac in E12.5 control versus LHX2cKO cortical tissue. y-axis indicates fold change over control at the
respective loci.B, Diagramdepictingproposedmodel of chromatin loopingbringingdistant regulatory elements andTSSnear each
other. We propose that LHX2 binding to the regulatory elements of its target genes Fezf2 and Sox11 recruits the NuRD subunits
LSD1 and HDAC2, which associate with the TSS and the LHX2 binding region, leading to erasure of active marks. In the absence of
LHX2, the active marks are enriched. Error bars indicate SEM. *p 0.05. **p 0.001. ***p 0.0001.
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LSD1 can be associated with the NuRD complex (Wang et al.,
2009) or also the CoREST repressor complex (Yang et al., 2006;
Wang et al., 2007). RBBP4 is associated with the Polycomb re-
pressive complex (PRC2) (Kuzmichev et al., 2002). Thus, LHX2
mayassociatewithspecificchromatinmodifiersinacontext-dependent
manner. Exploring the changing nature of such associations will
give new insights to the temporally dynamic controls on cell fate
specification.
Furthermore, we demonstrate that there are functional con-
sequences within a day of loss of LHX2. These include an increase
in the H3K9Ac and H3K4Me3 epigenetic marks that are associ-
ated with actively transcribed genes (Karmodiya et al., 2012) as
well as an abnormal overexpression of the target genes in the
ventricular zone by E12.5, an effect that attenuates by E13.5.
Layer 5 neurons are produced during this timewindow, and there
is a corresponding increase in the Fezf2/CTIP2-expressing layer
5 SCPN-like neurons seen at postnatal stages.
As a final test of LHX2 function, overexpression of Lhx2 at
E12.5 has the opposite effect of dramatically reducing the number
of CTIP2-expressing neurons. Given the normally high levels of
Lhx2 in the cortical primordium, the effects of Lhx2 overexpres-
sion may arise due to its continued expression in postmitotic
deep layer neurons in which it is normally not expressed. This
suggests that LHX2may be able to epigenetically silence its targets
in postmitotic neurons as well. Although additional work is
needed to understand how Lhx2 fits in with the other known
regulators of Fezf2, our study offers new directions and insight on
how this question may be explored further in progenitors and
postmitotic neurons.
Of the many roles reported for LHX2 in the literature, this is
perhaps the most surprising, given that Lhx2 appears to be ex-
pressed in all progenitors at E10.5-E11.5 (Rinco´n-Limas et al.,
1999; Lu et al., 2000) and displays continued expression in a
gradient throughout the period of cortical neurogenesis (Bul-
chand et al., 2003). At E12.5, Lhx2 expression displays a gradient
in the cortical primordium, from caudomedialhigh to rostrolater-
al low (Nakagawa et al., 1999) (Fig. 5E). The fact that Lhx2 over-
expression at E12.5 is able to dramatically reduce the number of
postnatal CTIP2 expressing neurons in layer 5, and loss of Lhx2 is
able to increase them, indicates that levels of Lhx2 in the E12.5
neuroepithelium may play an important role in governing the
neuronal number corresponding to this population, together
with other regulators across the rostrocaudal axis. Work from
several groups has reported that regulators of neuronal subtype
identity, such as Fezf2, COUP-TF1, CB1R, and Cux2, display
widespread to limited expression in the ventricular zone (Hirata
et al., 2004; Nieto et al., 2004; Zimmer et al., 2004; Chen et al.,
2005; Molyneaux et al., 2005; Faedo et al., 2008; Cubelos et al.,
2010; Tomassy et al., 2010; Díaz-Alonso et al., 2012, 2015;
Rodríguez-Tornos et al., 2016). Of these, Fezf2 is expressed
widely in the ventricular zone at E12.5 but is seen only in post-
mitotic neurons by E15.5 (Hirata et al., 2004), and neurons in all
cortical layers appear to originate from FEZF2 lineage (Guo et
al., 2013). Although this immediately suggests a strong parallel
with the temporal fate specificationmodel that has been elegantly
described in Drosophila neuroblasts (Kohwi and Doe, 2013), the
function of ventricular Fezf2, if any, in determining postmitotic
identity of subcerebral projection neurons remains to be eluci-
Figure 5. LHX2 is necessary and sufficient to regulate molecular subtype identity. A, B, Electroporation of control GFP (A) or LHX2-GFP (B) at E12.5 and examination at P5 reveal GFP-expressing
cells in the region of electroporation, overlappingwith CTIP2-expressing layer 5 cells. Individual high-magnification confocal images of GFP, CTIP2, SATB2, and the correspondingmerged images of
GFP/CTIP2 and GFP/SATB2 are shown alongside the low-magnification GFP/CTIP2 image. C, Diagram illustrating in utero electroporation at E12.5, and examination of brain sections at P5. D, The
percentage of electroporated (GFP-expressing) cells that also express CTIP2 or SATB2 reveals a striking decrease in CTIP2-expressing cells and an increase in SATB2-expressing cells upon electropo-
ration of LHX2-GFP. E, A gradient of Lhx2 expression is seen in a series of sagittal sections at E12.5. Scale bars:A,B, 500m(low-magnification images), 50m(high-magnification images); E, 500
m. Error bars indicate SEM. **p 0.001.
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dated, and our finding that loss of LHX2 results in an upregula-
tion of Fezf2 in the ventricular zone itself adds furthermotivation
to exploring this question.
Our study motivates a mechanistic analysis of the transcrip-
tion factor network that controls cortical neuronal subtype iden-
tity, from an epigenetic angle. It is important to unravel what
terms, such as induction or suppression, actually entail at the
level of the chromatin. Such an analysis may offer some clarity on
why some genes appear more responsive to regulatory controls
(e.g., whether they are in an epigenetically “poised” state), with
both active and repressive marks, in which case they can be in-
duced or suppressed with short time delays (Bernstein et al.,
2006; Mikkelsen et al., 2007; Hirabayashi and Gotoh, 2010). In
some cases, transcription factors may compete for or sequester
key components of chromatin remodeling complexes and cause
regulation of target genes in this fashion. One example of this is
the regulation of Ctip2 by SATB2 and LMO4 (Harb et al., 2016).
This study elegantly demonstrates that LMO4 binds and seques-
ters HDAC1 and prevents it from participating in the SATB2-
NuRD complex that normally suppresses Ctip2. In addition to
the protein complexes that bind chromatin, distal enhancers as-
sociated with any target gene locus are equally important. For
example, Shim et al. (2012) identified a region 7.3 kb downstream
of the Fezf2 TSS termed the E4 enhancer, which is the region at
which activators of Fezf2, SOX4 and SOX11, compete for binding
with repressor SOX5. SATB2 also binds this enhancer and posi-
tively regulates the expression of Fezf2 in cortical neurons (McK-
enna et al., 2015). This enhancer is most strongly expressed in
cortical progenitors and possibly drives the expression of FEZF2
in these cells (Eckler et al., 2014). How the activation or repres-
sion is achieved via this distal regulatory element will almost
certainly be a fascinating story of epigenetic regulation of Fezf2.
Moreover, in a role strikingly similar to that of LHX2, a recent
study demonstrated that transcription factor CTIP1, expressed
by newly postmitotic neurons, functions to specify SCPN versus
CThPN identity in the cortex (Woodworth et al., 2016). It is in
such a context that our results are of immediate interest because
we position LHX2 among the known regulators of neuronal sub-
type identity that are expressed in the ventricular zone, the
interactions of which are likely to determine area specific com-
plements of deep layer neuronal subtypes along the rostrocaudal
and mediolateral axes of the developing cortex.
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